297 related articles for article (PubMed ID: 24184331)
1. Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment.
Maxwell G; MacKay C; Cubberley R; Davies M; Gellatly N; Glavin S; Gouin T; Jacquoilleot S; Moore C; Pendlington R; Saib O; Sheffield D; Stark R; Summerfield V
Toxicol In Vitro; 2014 Feb; 28(1):8-12. PubMed ID: 24184331
[TBL] [Abstract][Full Text] [Related]
2. Application of a systems biology approach to skin allergy risk assessment.
Maxwell G; Mackay C
Altern Lab Anim; 2008 Nov; 36(5):521-56. PubMed ID: 19025322
[TBL] [Abstract][Full Text] [Related]
3. From pathways to people: applying the adverse outcome pathway (AOP) for skin sensitization to risk assessment.
MacKay C; Davies M; Summerfield V; Maxwell G
ALTEX; 2013; 30(4):473-86. PubMed ID: 24173169
[TBL] [Abstract][Full Text] [Related]
4. A future approach to measuring relative skin sensitising potency: a proposal.
Jowsey IR; Basketter DA; Westmoreland C; Kimber I
J Appl Toxicol; 2006; 26(4):341-50. PubMed ID: 16773645
[TBL] [Abstract][Full Text] [Related]
5. Determinants of skin sensitisation potential.
Roberts DW; Aptula AO
J Appl Toxicol; 2008 Apr; 28(3):377-87. PubMed ID: 17703504
[TBL] [Abstract][Full Text] [Related]
6. The adverse outcome pathway for skin sensitisation: Moving closer to replacing animal testing.
Schultz TW; Dimitrova G; Dimitrov S; Mekenyan OG
Altern Lab Anim; 2016 Oct; 44(5):453-460. PubMed ID: 27805828
[TBL] [Abstract][Full Text] [Related]
7. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
[TBL] [Abstract][Full Text] [Related]
8. Chemical reactivity indices and mechanism-based read-across for non-animal based assessment of skin sensitisation potential.
Roberts DW; Aptula AO; Patlewicz G; Pease C
J Appl Toxicol; 2008 May; 28(4):443-54. PubMed ID: 17703503
[TBL] [Abstract][Full Text] [Related]
9. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
10. The use of peptide reactivity assays for skin sensitisation hazard identification and risk assessment.
Gerberick GF
Altern Lab Anim; 2016 Oct; 44(5):437-442. PubMed ID: 27805826
[TBL] [Abstract][Full Text] [Related]
11. The Dermal Sensitisation Threshold- a TTC approach for allergic contact dermatitis.
Safford RJ
Regul Toxicol Pharmacol; 2008 Jul; 51(2):195-200. PubMed ID: 18406502
[TBL] [Abstract][Full Text] [Related]
12. Allergic contact dermatitis: a commentary on the relationship between T lymphocytes and skin sensitising potency.
Kimber I; Maxwell G; Gilmour N; Dearman RJ; Friedmann PS; Martin SF
Toxicology; 2012 Jan; 291(1-3):18-24. PubMed ID: 22120538
[TBL] [Abstract][Full Text] [Related]
13. Principles for identification of High Potency Category Chemicals for which the Dermal Sensitisation Threshold (DST) approach should not be applied.
Roberts DW; Api AM; Safford RJ; Lalko JF
Regul Toxicol Pharmacol; 2015 Aug; 72(3):683-93. PubMed ID: 25765509
[TBL] [Abstract][Full Text] [Related]
14. Consideration of criteria required for assignment of a (skin) sensitiser a substance of very high concern (SVHC) under the REACH regulation.
Basketter D; Kimber I
Regul Toxicol Pharmacol; 2014 Aug; 69(3):524-8. PubMed ID: 24893346
[TBL] [Abstract][Full Text] [Related]
15. Towards AOP application--implementation of an integrated approach to testing and assessment (IATA) into a pipeline tool for skin sensitization.
Patlewicz G; Kuseva C; Kesova A; Popova I; Zhechev T; Pavlov T; Roberts DW; Mekenyan O
Regul Toxicol Pharmacol; 2014 Aug; 69(3):529-45. PubMed ID: 24928565
[TBL] [Abstract][Full Text] [Related]
16. An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing.
McKim JM; Keller DJ; Gorski JR
Cutan Ocul Toxicol; 2012 Dec; 31(4):292-305. PubMed ID: 22494060
[TBL] [Abstract][Full Text] [Related]
17. Refinement of the Dermal Sensitisation Threshold (DST) approach using a larger dataset and incorporating mechanistic chemistry domains.
Safford RJ; Aptula AO; Gilmour N
Regul Toxicol Pharmacol; 2011 Jul; 60(2):218-24. PubMed ID: 21447365
[TBL] [Abstract][Full Text] [Related]
18. TIMES-SS--recent refinements resulting from an industrial skin sensitisation consortium.
Patlewicz G; Kuseva C; Mehmed A; Popova Y; Dimitrova G; Ellis G; Hunziker R; Kern P; Low L; Ringeissen S; Roberts DW; Mekenyan O
SAR QSAR Environ Res; 2014; 25(5):367-91. PubMed ID: 24785905
[TBL] [Abstract][Full Text] [Related]
19. An alternative approach for the safety evaluation of new and existing chemicals, an exercise in integrated testing.
Gubbels-van Hal WM; Blaauboer BJ; Barentsen HM; Hoitink MA; Meerts IA; van der Hoeven JC
Regul Toxicol Pharmacol; 2005 Aug; 42(3):284-95. PubMed ID: 15979772
[TBL] [Abstract][Full Text] [Related]
20. Regulatory use of (Q)SARs in toxicological hazard assessment strategies.
Gerner I; Spielmann H; Hoefer T; Liebsch M; Herzler M
SAR QSAR Environ Res; 2004; 15(5-6):359-66. PubMed ID: 15669695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
